Newtyn Management’s Mural Oncology MURA Stock Holding History

Newtyn Management’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-522,919	Closed	-$1.08M	–	38
2025 Q3	$1.08M	Sell	522,919 -47,081	-8%	-$101K	0.13%	33
2025 Q2	$1.41M	Hold	570,000	–	–	0.21%	34
2025 Q1	$718K	Hold	570,000	–	–	0.11%	30
2024 Q4	$1.84M	Hold	570,000	–	–	0.32%	31
2024 Q3	$1.78M	Hold	570,000	–	–	0.27%	33
2024 Q2	$1.79M	Buy	570,000 +70,000	+14%	+$258K	0.34%	31
2024 Q1	$2.44M	Buy	500,000 +55,000	+12%	+$267K	0.49%	28
2023 Q4	$2.63M	Buy	+445,000	New	+$1.79M	0.52%	30

Newtyn Management's MURA Position: Q4 2025 in Review

Newtyn Management sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 522,919 shares — an estimated $1.08M sold.

Newtyn Management first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $2.63M in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Newtyn Management reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Newtyn Management sold 522,919 Mural Oncology shares in Q4 2025, an estimated $1.08M.
Newtyn Management first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Newtyn Management's Mural Oncology position peaked at $2.63M in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Newtyn Management's 13F filing for Q4 2025, filed 17 Feb 2026.